The combination of these agents has been shown to synergistically inhibit tumor cell proliferation and induce apoptosis, primarily through the suppression of the phosphoinositide 3-kinase (PI3K)/AKT/mTOR signaling axis [17,18,19]. Here, AKT1 is linked to neoplasm.